# Anocca

> Developing T-cell immunotherapies

Business model and tags: B2B, Manufacturing, Pharma & life sciences, Has production sites

## About Anocca

Specializing in T-cell biology, Anocca develops cutting-edge immunotherapies and vaccines to target oncology, infectious diseases, and autoimmunity, with a focus on TCR-T therapies

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 51–250 employees
- **Headquarters**: Södertälje, Stockholm County, Sweden
- **Founded**: 2014
- **Revenue**: SEK 139M – SEK 1.1B (Tamtam estimate)
- **Website**: [anocca.com](https://www.anocca.com/)
- **LinkedIn**: [linkedin.com/company/anocca-ab](https://www.linkedin.com/company/anocca-ab)

## Anocca at a glance

Anocca is a B2B company in the Biotechnology Research industry, headquartered in Södertälje, Stockholm County, Sweden.

Anocca was founded in 2014.

Anocca has 51–250 employees.

Anocca's revenue is SEK 139M – SEK 1.1B (Tamtam estimate).

## Frequently asked questions about Anocca

### What is Anocca's revenue?

Tamtam estimates Anocca's annual revenue at SEK 139M – SEK 1.1B.

### How many employees does Anocca have?

Anocca has 51–250 employees.

### Where is Anocca headquartered?

Anocca is headquartered in Södertälje, Stockholm County, Sweden.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/anocca